Kevin Martinolich, MD
Sleep Medicine · Knoxville, TNNPI 1659388197
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,520 of the $8,653 with a category attached, or 63.8%. 15 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 32.9% of the total. Reporting peaked in 2023 at $4,430 and has fallen 96.1% since, to $172 in 2025.
Across 151 payments — averaging $57.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$3K
- ZOLL Respicardia, Inc.$2K
- Jazz Pharmaceuticals Inc.$2K
- Axsome Therapeutics, Inc.$683
- Harmony Biosciences LLC$378
- Avadel CNS Pharmaceuticals, LLC$324
- plus $633 from 9 others
What the payments were for
- Travel & lodging$2,78632%
- Food & beverage$5,52064%
- Education$3474%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 21 | $2,850 |
| ZOLL Respicardia, Inc. | 12 | $2,118 |
| Jazz Pharmaceuticals Inc. | 53 | $1,667 |
| Axsome Therapeutics, Inc. | 22 | $683 |
| Harmony Biosciences LLC | 9 | $378 |
| Avadel CNS Pharmaceuticals, LLC | 12 | $324 |
| Philips North America LLC | 12 | $268 |
| Cook Medical LLC | 1 | $81 |
| Itamar Medical Inc | 1 | $79 |
| Breas Medical, Inc. | 1 | $74 |
| Resmed Corp | 3 | $51 |
| UCB, Inc. | 1 | $24 |
| Fisher & Paykel Healthcare Inc | 1 | $22 |
| Azurity Pharmaceuticals, Inc. | 1 | $17 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- remede System$1,914
- Inspire$1,333
- Inspire Upper Airway Stimulation System$1,226
- XYWAV$122
- SUNOSI$122
- XYREM$121
- Wakix$112
How this compares
$8,653 in reported general payments places this provider in the 85th percentile of 41 sleep medicine providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XyremSodium Oxybate | 20 | $275,504 |
| LumryzSodium Oxybate | 13 | $241,692 |
| WakixPitolisant Hcl | 24 | $176,977 |
| SunosiSolriamfetol Hcl | 30 | $28,974 |
| NeuproRotigotine | 15 | $20,929 |
| BelsomraSuvorexant | 39 | $15,643 |
| Modafinil | 66 | $9,975 |
| Atomoxetine Hcl | 25 | $2,715 |
| SymbicortBudesonide/Formoterol Fumarate | 12 | $2,599 |
| Armodafinil | 40 | $2,309 |
| Gabapentin | 195 | $2,215 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 35 | $1,664 |
| Temazepam | 15 | $1,316 |
| Ramelteon | 12 | $1,310 |
| Trazodone Hcl | 75 | $740 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Avadel CNS Pharmaceuticals, LLCLumryz | $324 | $241,69213 claims |
| Harmony Biosciences LLCWakix | $378 | $176,97724 claims |
| Axsome Therapeutics, Inc.Sunosi | $683 | $28,97430 claims |
| UCB, Inc.Neupro | $24 | $20,92915 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 41 sleep medicine providers in Tennessee.
Other sleep medicine in Knoxville
- Prashant JamesKnoxville$11K
- Christopher NolteKnoxville$7K
- Ehab MansoorKnoxville$894
- Farrukh SiddiquiKnoxville$208
- John ThomasKnoxville$147
- Bijoy JohnBrentwood$38K
- Kelly CardenNashville$24K
- Martha HagamanFranklin$20K
- John DenglerJohnson City$19K
- Merrill WiseMemphis$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.